Document Classification

Section Type: RESULTS

Text: EZE/SIMVA produced greater reductions in LDL-C (-27. 7 % vs. -16. 9 % ; p < or = 0. 001), total cholesterol (-17. 5 % vs. -10. 3 % ; p < or = 0. 001), non-high-density lipoprotein cholesterol (HDL-C) (-23. 4 % vs. -14. 0 % ; p < or = 0. 001) and apolipoprotein B (-17. 9 % vs. -9. 8 % ; p < or = 0. 001) compared with ROSUVA, while both treatments were equally effective at increasing HDL-C (2. 1 % vs. 3. 0 % ; p = 0. 433).